Virios therapeutics to report third quarter 2023 financial results on monday, november 13, 2023

Atlanta, nov. 06, 2023 (globe newswire) -- virios therapeutics, inc. (nasdaq: viri) (the “company”), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“fm”) and long-covid, announced today that it will report third quarter 2023 financial results on monday, november 13, 2023 before the open of the financial markets. management will also host a webcast and conference call on november 13, 2023 at 8:30 a.m. et to discuss the results and provide a corporate update.
VIRI Ratings Summary
VIRI Quant Ranking